You're viewing a public preview of Mithril Medicine Sign up free to access full investment history, financials, executives & more

Mithril Medicine

Active
Sector: Life Science Entity: Private
1
Transactions
Sign up to view
About Mithril Medicine
Mithril Medicine is a biotechnology company that develops bispecific "bridging" antibodies for two rare, severe forms of muscular dystrophy: LAMA2-related congenital muscular dystrophy (LAMA2-CMD) and alpha-dystroglycanopathy. It ran as a "pipeline-in-a-person". Its founder was the only full-time employee and used Claude to coordinate contracts, logistics and experiments across 11 outside laboratories, with support from part-time scientific consultants. In under 18 months it took an antibody therapy for LAMA2-CMD from idea to positive preclinical mouse studies. Mice on the highest dose showed roughly double the grip and muscle strength of untreated mice, but no human trials have started yet. Its intended beneficiaries are children with these rare diseases, and its research has been carried out through contract labs in the United States. The company is headquartered in Cambridge, Massachusetts, United States.
Investors
Current Investors
Anthropic PBC ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Investment Details
1 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 1 Transaction
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Mithril Medicine M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does Mithril Medicine do?
Mithril Medicine is a biotechnology company that develops bispecific "bridging" antibodies for two rare, severe forms of muscular dystrophy: LAMA2-related congenital muscular dystrophy (LAMA2-CMD) and alpha-dystroglycanopathy. It ran as a "pipeline-in-a-person". Its founder was the only full-time em
Where is Mithril Medicine headquartered?
Location information for Mithril Medicine is available on AcquityData.
When was Mithril Medicine founded?
Founded year information for Mithril Medicine is available on AcquityData.
What sector is Mithril Medicine in?
Mithril Medicine operates in the Life Science sector.
Who are the investors in Mithril Medicine?
Current investors in Mithril Medicine include Anthropic PBC. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Mithril Medicine been involved in?
Mithril Medicine has 1 transaction tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Mithril Medicine profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Mithril Medicine's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial